<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Opinion Health - Latest Health News</title>
    <link>http://opinionhealth.co.uk/</link>
    <pubDate>Thu, 11 Mar 2010 08:27:07 GMT</pubDate>
    <description>A summary of the latest news on healthcare, as reported by the UK and International media</description>
    <item>
      <title>FDA will review Fosamax, Boniva for safety</title>
      <link>http://opinionhealth.co.uk/r/4840</link>
      <description>The Food and Drug Administration said [on] Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures.</description>
      <pubDate>Thu, 11 Mar 2010 08:27:07 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4492</guid>
    </item>
    <item>
      <title>FDA rejects Actelion's Zavesca for rare NP-C disease </title>
      <link>http://opinionhealth.co.uk/r/4839</link>
      <description>Actelion&#8217;s bid to get a new use approved for Gaucher disease drug Zavesca has suffered a setback after regulators in the USA asked more information on the drug as a treatment for a rarer condition.</description>
      <pubDate>Thu, 11 Mar 2010 08:26:35 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4491</guid>
    </item>
    <item>
      <title>FDA panel backs InterMune's Esbriet for IPF </title>
      <link>http://opinionhealth.co.uk/r/4837</link>
      <description>Shares in InterMune will soar today after advisors to the US Food and Drug Administration voted in favour of recommending Esbriet for approval as a treatment for lung scarring.</description>
      <pubDate>Thu, 11 Mar 2010 08:26:13 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4490</guid>
    </item>
    <item>
      <title>C&amp;W wins diabetes work</title>
      <link>http://opinionhealth.co.uk/r/4836</link>
      <description>Merck Sharp &amp; Dohme has selected Cohn &amp; Wolfe to handle the PR for its type two diabetes treatment, Januvia, after a competitive pitch. The brief is believed to be worth &#163;1m and will be headed by C&amp;W's London healthcare team.</description>
      <pubDate>Thu, 11 Mar 2010 08:25:44 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4489</guid>
    </item>
    <item>
      <title>Porter Novelli snares former Hill &amp; Knowlton healthcare boss Shipra </title>
      <link>http://opinionhealth.co.uk/r/4835</link>
      <description>Porter Novelli has signed former Hill &amp; Knowlton healthcare chief Shipra Singh to head its EMEA healthcare business.</description>
      <pubDate>Thu, 11 Mar 2010 08:25:28 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4488</guid>
    </item>
    <item>
      <title>Ark considers bids after failure of brain tumour drug trial</title>
      <link>http://opinionhealth.co.uk/r/4833</link>
      <description>Ark Therapeutics, the AIM-listed pharmaceuticals group, said yesterday that it would consider offers for the company after its potential brain cancer treatment, Cerepro, was rejected by European regulators</description>
      <pubDate>Thu, 11 Mar 2010 08:25:10 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4487</guid>
      <author>The Independent</author>
    </item>
    <item>
      <title>Abbott to acquire Facet Biotech</title>
      <link>http://opinionhealth.co.uk/r/4830</link>
      <description>Abbott is to acquire Californian-based Facet Biotech in a deal valued at approximately $722m.</description>
      <pubDate>Thu, 11 Mar 2010 08:24:37 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4486</guid>
      <author>PMLive</author>
    </item>
    <item>
      <title>Botox approved for upper limb spasticity</title>
      <link>http://opinionhealth.co.uk/r/4829</link>
      <description>Allergan has announced that the US FDA has approved Botox (onabotulinumtoxinA) for the treatment of increased elbow, wrist and finger muscle stiffness in adults with upper limb spasticity.</description>
      <pubDate>Thu, 11 Mar 2010 08:23:35 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4485</guid>
      <author>PMLive</author>
    </item>
    <item>
      <title>Teva appoints Dr Phillip Frost as chair</title>
      <link>http://opinionhealth.co.uk/r/4828</link>
      <description>Israeli generics manufacturer, Teva has announced the appointment of Dr Phillip Frost to the role of chairman of the Board of Directors.</description>
      <pubDate>Thu, 11 Mar 2010 08:23:03 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4484</guid>
      <author>PMLive</author>
    </item>
    <item>
      <title>Time for drug giants to jump into the patent pool?</title>
      <link>http://opinionhealth.co.uk/r/4827</link>
      <description>While drugmaking giant GlaxoSmithKline has picked up a load of good press for CEO Andrew Witty's developing world initiatives - from ploughing back some of the (tiny) profits made in Africa to the more interesting patent pool it announced for neglected tropical diseases - it is Californian rival Gilead that gets a higher approval rating at the moment from Aids campaigners.</description>
      <pubDate>Thu, 11 Mar 2010 08:21:27 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4483</guid>
      <author>The Guardian</author>
    </item>
    <item>
      <title>Low diagnostic yield of elective coronary angiography</title>
      <link>http://opinionhealth.co.uk/r/4826</link>
      <description>Background - Guidelines for triaging patients for cardiac catheterisation recommend a risk assessment and noninvasive testing.</description>
      <pubDate>Thu, 11 Mar 2010 08:21:02 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4482</guid>
      <author>New England Journal of Medicine</author>
    </item>
    <item>
      <title>Diabetes injection Byetta LAR faces Food and Drug Administration decision</title>
      <link>http://opinionhealth.co.uk/r/4825</link>
      <description>Following clinical trials, considerable investment and a great deal of anticipation the long-action version of diabetes drug Byetta now faces an approval decision by the [US] Food and Drug Administration.</description>
      <pubDate>Thu, 11 Mar 2010 08:20:38 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4481</guid>
    </item>
    <item>
      <title>Doctors 'failing to give correct cholesterol targets'</title>
      <link>http://opinionhealth.co.uk/r/4824</link>
      <description>Many lives could be saved if GPs followed guidelines for reducing cholesterol in patients at high risk of heart disease, research suggests.</description>
      <pubDate>Thu, 11 Mar 2010 08:20:18 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4480</guid>
      <author>BBC</author>
    </item>
    <item>
      <title>Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing</title>
      <link>http://opinionhealth.co.uk/r/4823</link>
      <description>Objectives - To examine the relation between health and several dimensions of sexuality and to estimate years of sexually active life across sex and health groups in middle aged and older adults.</description>
      <pubDate>Wed, 10 Mar 2010 08:29:44 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4479</guid>
      <author>BMJ</author>
    </item>
    <item>
      <title>Virus can attack prostate cancer</title>
      <link>http://opinionhealth.co.uk/r/4822</link>
      <description>Researchers in Alberta have successfully tested a new viral approach to treating prostate cancer in a small number of men.</description>
      <pubDate>Wed, 10 Mar 2010 08:29:29 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/4478</guid>
      <author>CBC</author>
    </item>
  </channel>
</rss>
